BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,972.59
      0.05%
      US Tech 100
      20,219.60
      -0.06%
      Dow Jones
      44,549.05
      0.57%
      Brent Oil
      72.625
      -2.87%
      Bitcoin
      95,021.62
      -3.08%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AtriCure Inc (ATRC)

      7. AtriCure Inc (ATRC) News

      AtriCure Inc

      AtriCure Inc (ATRC)

      NASDAQ
      35.92
      0.185
      ( 0.52% )
      Updated: 12:26:13
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      ATRC News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      August 19 2024
      ATRC (0.52%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      August 15 2024
      ATRC (0.52%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      August 01 2024
      ATRC (0.52%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      July 31 2024
      ATRC (0.52%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      July 30 2024
      ATRC (0.52%)

      Form SD - Specialized disclosure report
      Edgar (US Regulatory)
      May 31 2024
      ATRC (0.52%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 31 2024
      ATRC (0.52%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 14 2024
      ATRC (0.52%)

      ATRC Discussion

      View Posts
      mlkrborn mlkrborn 11 years ago
      HISTORY
      Initial Public Offering



      On August 10, 2005, we consummated an initial public offering of 4.6 million shares of our common stock at $12.00 per share, which includes the underwriters exercise of their over-allotment option, on August 9, 2005, to purchase 600,000 shares of our common stock of which 450,000 shares were sold by selling shareholders and 150,000 shares were sold by us. We did not receive any proceeds from the sale of the 450,000 shares of common stock that were sold by selling shareholders. These share amounts reflect a 1-for-3.8 reverse split of our capital stock that was effected on July 27, 2005. Proceeds to us from the offering, after deducting underwriting discounts and commissions but before expenses, were $46.3 million. Expenses are estimated to be approximately $3.25 million.



      15
      👍️0
      mlkrborn mlkrborn 11 years ago
      AtriCure receives FDA approval for investigational study to evaluate stroke prevention in atrial fibrillation (ATRC) 14.35 : Co announces the FDA approval to begin enrollment in a clinical study of AtriCure's AtriClip Left Atrial Appendage Exclusion System. The study will evaluate the use of the AtriClip device to prevent stroke in patients with Afib. The feasibility study will enroll Afib patients at seven medical centers across the country. The study will focus on patients with risk factors that place them at significant risk of stroke as well as substantial bleeding risks that contraindicate them for anticoagulation therapy. Research suggests that up to 40% of patients are unable to take oral anticoagulants due to excessive risk of bleeding.
      👍️0
      dmarkg dmarkg 12 years ago
      Hey Wobblenuts and Jackie Scan I want to show you something....

      Medical Breakthrough Wound Stasis Technology

      ATRC and EPGL could possibly go hand in hand here...
      Merry Christmas 2012

      Merry Chirstmas 2012, friends.
      👍️0
      wobblenuts wobblenuts 12 years ago
      Any talks involving ATRC and soon to be sub penny wonder EPGL?



      Are they hinting at something here?


      1)"ATRC fully SEC reporting financials are available at OTCMARKETS for EPGL investors to see as an example of where EPGL management is headed."

      2)"EPGL initiating R&D on 4 new medical devices before end of 2012."

      3)"Property and equipment, net 0"
      👍️0
      Penny Roger$ Penny Roger$ 13 years ago
      ~ Monday! $ATRC ~ Earnings posted, pending or coming soon! In Charts and Links Below!

      ~ $ATRC ~ Earnings expected on Monday *
      Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
      One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








      http://stockcharts.com/h-sc/ui?s=ATRC&p=D&b=3&g=0&id=p88783918276&a=237480049




      http://stockcharts.com/h-sc/ui?s=ATRC&p=W&b=3&g=0&id=p54550695994



      ~ Google Finance: http://www.google.com/finance?q=ATRC
      ~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ATRC#
      ~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ATRC+Key+Statistics
      ~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ATRC
      Finviz: http://finviz.com/quote.ashx?t=ATRC
      ~ BusyStock: http://busystock.com/i.php?s=ATRC&v=2


      <<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ATRC >>>>>>



      http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

      *If the earnings date is in error please ignore error. I do my best.
      👍️0
      Penny Roger$ Penny Roger$ 13 years ago
      AtriCure, Inc., is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue. Its primary product line, which accounts for a majority of its revenues, is Isolator Synergy bipolar ablation clamp system (Isolator system) and related radiofrequency ablation devices. It also offers a cryoablation product line, which features reusable and disposable cryoablation devices. In addition, it offers the AtriClip Gillinov-Cosgrove Left Atrial Appendage System, or AtriClip system, which is designed to exclude the left atrial appendage.

      http://www.google.com/finance?q=ATRC
      👍️0

      Your Recent History

      NASDAQ
      ATRC
      AtriCure
      Delayed Upgrade Clock